Covered recipient · General Payments record
ALEXANDRIA POLANCO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,607.26
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $567.29 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $232.01 | 6 |
| ABBVIE INC. | $104.50 | 2 |
| Acerta Pharma LLC | $76.93 | 3 |
| SI-BONE, INC. | $52.73 | 2 |
| Gilead Sciences, Inc. | $29.41 | 1 |
| Abbott Laboratories | $21.96 | 1 |
| ALK-Abello, Inc | $20.30 | 1 |
| Amgen Inc. | $15.44 | 1 |
| ViiV Healthcare Company | $14.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.96 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125185309 | CMS |
| ABBVIE INC. | $23.77 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108026552 | CMS |
| ABBVIE INC. | $80.73 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108026554 | CMS |
| ALK-Abello, Inc | $20.30 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099894297 | CMS |
| Amgen Inc. | $15.44 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657405 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.70 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104588484 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.17 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104618730 | CMS |
| AstraZeneca Pharmaceuticals LP | $30.06 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105580996 | CMS |
| Gilead Sciences, Inc. | $29.41 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133693442 | CMS |
| Lilly USA, LLC | $19.79 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135493700 | CMS |
| Lilly USA, LLC | $20.65 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135493698 | CMS |
| Lilly USA, LLC | $27.99 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135493702 | CMS |
| Lilly USA, LLC | $22.13 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135513702 | CMS |
| Lilly USA, LLC | $124.99 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135518976 | CMS |
| Lilly USA, LLC | $16.46 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135484251 | CMS |
| SI-BONE, INC. | $25.93 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120070259 | CMS |
| SI-BONE, INC. | $26.80 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120075026 | CMS |
| ViiV Healthcare Company | $14.01 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112794480 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.